Clinical Trial Update: Effects of Chimeric Natriuretic Peptide Versus Placebo in Stable Heart Failure and Moderate Renal Dysfunction [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating chimeric natriuretic peptide versus placebo in patients with stable heart failure and moderate renal dysfunction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Renal Insufficiency

Drugs mentioned

• Chimeric natriuretic peptide

Snippet

Sponsor: John A. Schirger | Conditions: Heart Failure, Renal Insufficiency | Phase 1 | Status: WITHDRAWN